Ä¢¹½AV

Researchers Farrokh Alemi and Kevin Lybarger receive George Mason Ä¢¹½AV’s first Patient-Centered Outcomes Research Institute (PCORI) award to develop innovative AI technology, including large language models, for improving antidepressant recommendations.

Professor Farrokh Alemi receives NIH grant to pilot first-of-its-kind, evidence-based artificial intelligence tool to address the medication needs of Black and African American people with depression. This is part of the college’s Innovate for Good story series. 

MeAgainMeds.com, a free AI-powered website, helps clinicians more effectively match patients with the optimal antidepressant using big data.

Web site developed based on the study can help alleviate depression symptoms more effectively.